S. O’Neill

发表

A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Amanda L. Graham, D. Farrell, M. Schwartz, 2017, Contemporary clinical trials.

Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off

T. Lieu, S. Ramsey, J. Mandelblatt, 2020, The Patient - Patient-Centered Outcomes Research.

Preferences for Genetic and Behavioral Health Information: The Impact of Risk Factors and Disease Attributions

C. McBride, K. Kaphingst, S. O’Neill, 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2003, Journal of Genetic Counseling.

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer

R. Gray, C. Isaacs, J. Mandelblatt, 2019, JNCI cancer spectrum.

Women’s concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children

A. Patenaude, J. Garber, B. Peshkin, 2014, Journal of Community Genetics.

Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.

C. McBride, D. Roter, K. Tercyak, 2012, Professional psychology, research and practice.

Adolescent medical providers' willingness to recommend genetic susceptibility testing for nicotine addiction and lung cancer risk to adolescents.

B. Peshkin, K. Tercyak, G. Luta, 2009, Journal of pediatric psychology.

The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes

G. Bepler, C. McBride, I. Lipkus, 2008, Genetics in Medicine.

Primary care providers’ willingness to recommend BRCA1/2 testing to adolescents

B. Peshkin, K. Tercyak, G. Luta, 2010, Familial Cancer.

Conveying genomic recurrence risk estimates to patients with early‐stage breast cancer: oncologist perspectives

C. Isaacs, B. Peshkin, M. Schwartz, 2013, Psycho-oncology.

Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.

Hillary A. Robertson, B. Peshkin, Hillary A Robertson, 2019, Translational behavioral medicine.

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, Elizabeth Poggi, 2020, Breast Cancer Research and Treatment.

Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy

C. Isaacs, N. Brewer, M. Schwartz, 2016, Breast Cancer Research and Treatment.

Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives

C. Isaacs, J. Clapp, J. Mandelblatt, 2018, Journal of health communication.

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2018, Breast Cancer Research and Treatment.

What Can Interest Tell Us about Uptake of Genetic Testing? Intention and Behavior amongst Smokers Related to Patients with Lung Cancer

G. Bepler, L. Bastian, S. Sanderson, 2009, Public Health Genomics.

Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial.

M. Schwartz, K. Leppig, K. Ehrlich, 2020, The Permanente journal.

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2013, Journal of surgical oncology.

Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial

Tamara S. Roman, J. Berg, Julianne M. O’Daniel, 2021, Trials.

Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.

C. Isaacs, J. Garber, B. Peshkin, 2022, Pediatrics.

Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2021, Psycho-oncology.

Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes.

R. Street, C. Isaacs, S. Vadaparampil, 2020, JCO oncology practice.

Job Satisfaction in Cancer Prevention and Control: A Survey of the American Society of Preventive Oncology

L. Madlensky, K. Graves, J. Kapp, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Affect regulation as a moderator of intentions for breast cancer chemoprevention

B. Andersen, S. Vadaparampil, Claire C. Conley, 2022, Journal of Behavioral Medicine.

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population

C. Isaacs, B. Peshkin, S. Friedman, 2017, Familial Cancer.

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

C. Isaacs, J. Mandelblatt, C. Schechter, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinician and patient perspectives on screening mammography among women age 75 and older: A pilot study of a novel decision aid

M. Schonberg, R. Mishori, S. O’Neill, 2023, PEC innovation.

Multilevel Factors Impacting Mammography Screening Decisions in the Elderly: A Clinician and Patient Pilot

Dongyu Zhang, R. Mishori, S. O’Neill, 2020 .

Cost Effectiveness of Gene Expression Profile Testing in Community Practice.

T. Lieu, C. Isaacs, S. Ramsey, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Front Line of Genomic Translation

L. Koehly, C. McBride, L. Wideroff, 2012, Journal of cancer epidemiology.

Testing Different Communication Formats on Responses to Imagined Risk of Having Versus Missing the GSTM1 Gene

C. McBride, J. Shepperd, I. Lipkus, 2013, Journal of health communication.

A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy

Krysta Chaldekas, A. Bartholomew, M. Sosin, 2018, Front. Oncol..

Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.

C. Isaacs, V. Sheppard, S. O’Neill, 2015, Clinical breast cancer.

BRCA1/2 test results impact risk management attitudes, intentions, and uptake

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2010, Breast Cancer Research and Treatment.

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Suzanne O'Neill, Suzanne Leaman, H. Valdimarsdottir, 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report

C. Isaacs, M. Robson, B. Peshkin, 2021, Hereditary cancer in clinical practice.

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population

C. Isaacs, B. Peshkin, S. Friedman, 2018, Familial Cancer.

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support

C. Isaacs, B. Peshkin, C. Evans, 2016, Healthcare.

Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience

Andrea C. Johnson, D. Mays, K. Tercyak, 2015, Healthcare.

Women’s concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children

A. Patenaude, J. Garber, B. Peshkin, 2014, Journal of Community Genetics.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families

C. Isaacs, B. Peshkin, M. Schwartz, 2019, Journal of Cancer Education.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families

C. Isaacs, B. Peshkin, M. Schwartz, 2019, Journal of Cancer Education.

Predictors of genetic testing uptake in newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2020, Journal of surgical oncology.

Mammographic breast density as a risk factor for breast cancer: awareness in a recently screened clinical sample.

Erini Makariou, Edward Pien, E. Makariou, 2014, Women's health issues : official publication of the Jacobs Institute of Women's Health.

The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning?

J. Hay, K. Graves, S. O’Neill, 2014, Personalized medicine.

The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations

Ruth Etzioni, T. Lieu, S. Ramsey, 2018, Breast Cancer Research and Treatment.

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS

C. Isaacs, B. Peshkin, M. Schwartz, 2012, Journal of Cancer Epidemiology.

Young Smokers' Interpretations of the Estimated Lung Cancer Risk Associated with a Common Genetic Variant of Low Penetrance

C. McBride, J. Shepperd, I. Lipkus, 2014, Public Health Genomics.

Population‐based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

C. Isaacs, M. Schwartz, H. Tsai, 2015, Cancer.

Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study

G. Bepler, C. McBride, I. Lipkus, 2009, Cancer Epidemiology Biomarkers & Prevention.

Responses to Online GSTM 1 Genetic Test Results among Smokers Related to Patients with Lung Cancer : A Pilot Study

G. Bepler, C. McBride, I. Lipkus, 2009 .

Public Health Genomics

S. O’Neill, 2010 .

When genomic and standard test results diverge: implications for breast cancer patients’ preference for chemotherapy

B. Rimer, L. Carey, N. Brewer, 2009, Breast Cancer Research and Treatment.

Factors associated with annual-interval mammography for women in their 40s.

B. Rimer, J. DeFrank, J. Gierisch, 2009, Cancer epidemiology.

Retention and Use of Breast Cancer Recurrence Risk Information from Genomic Tests: The Role of Health Literacy

Sarah E Lillie, B. Rimer, L. Carey, 2007, Cancer Epidemiology Biomarkers & Prevention.

Prior breast density awareness, knowledge, and communication in a health system–embedded behavioral intervention trial

M. Schwartz, K. Wernli, E. Bowles, 2020, Cancer.

Young smokers’ views of genetic susceptibility testing for lung cancer risk: minding unintended consequences

C. McBride, J. Shepperd, I. Lipkus, 2011, Journal of Community Genetics.

Changes in Diet and Physical Activity Following BRCA1/2 Testing

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2008, Journal of psychosocial oncology.

Distress among women receiving uninformative BRCA1/2 results: 12‐month outcomes

Rachel E. Goldsmith, H. Valdimarsdottir, M. Schwartz, 2009, Psycho-oncology.

Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.

Rachel E. Goldsmith, H. Valdimarsdottir, B. Peshkin, 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

Patterns of Screening Mammography and Breast MRI During the COVID-19 Pandemic: A Retrospective, Chart-Review Study.

Claire C. Conley, G. Luta, Shan Sivanushanthan, 2023, Journal of breast imaging.

Characteristics associated with healthcare disruptions during the COVID-19 pandemic for women in the United States at high risk for breast cancer

S. Vadaparampil, Claire C. Conley, N. Brownstein, 2022, Preventive Medicine Reports.

Female Genital Mutilation/Cutting: sharing data and experiences to accelerate eradication and improve care: part 2

M. Boulvain, C. Efferson, L. Say, 2017, Reproductive Health.

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65

C. Isaacs, V. Sheppard, M. Schwartz, 2017, Breast Cancer Research.

Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.

C. Isaacs, M. Schwartz, H. Tsai, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Intentions to maintain adherence to mammography.

B. Rimer, J. Bowling, C. Skinner, 2008, Journal of women's health.

Engaging in Health Behaviors to Lower Risk for Breast Cancer Recurrence

L. Carey, J. DeFrank, N. Brewer, 2013, PloS one.

It's the amount of thought that counts: when ambivalence contributes to mammography screening delay.

B. Rimer, J. Gierisch, J. Bowling, 2012, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Women's interest in gene expression analysis for breast cancer recurrence risk.

Sarah E Lillie, B. Rimer, L. Carey, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65

C. Isaacs, V. Sheppard, M. Schwartz, 2017, Breast Cancer Research.

The interaction of post‐traumatic growth and post‐traumatic stress symptoms in predicting depressive symptoms and quality of life

Sarah E Lillie, B. Rimer, L. Carey, 2008, Psycho-oncology.

Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study

S. Vadaparampil, Claire C. Conley, S. O’Neill, 2022, Breast Cancer Research and Treatment.

Between-Race Differences in Supplemental Breast Cancer Screening Before and After Breast Density Notification Law.

T. Albrecht, Mark A Manning, S. O’Neill, 2019, Journal of the American College of Radiology : JACR.

Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial

Amanda L. Graham, J. Mandelblatt, D. Farrell, 2021, JNCI cancer spectrum.

Effect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast Density.

Amanda L. Graham, J. Mandelblatt, D. Farrell, 2021, Journal of women's health.

Contemplating Genetic Feedback Regarding Lung Cancer Susceptibility

C. McBride, J. Shepperd, I. Lipkus, 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

A New Approach to Assessing Affect and the Emotional Implications of Personal Genomic Testing for Common Disease Risk

C. McBride, K. Tercyak, S. O’Neill, 2015, Public Health Genomics.

Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions

C. Isaacs, J. Sparano, A. Kurian, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer

S. O’Neill, J. Jayasekera, A. Zhao, 2021, Breast.

Facilitators of peer coaching/support engagement and dissemination among women at risk for and surviving with breast cancer.

K. Tercyak, Kathryn Rehberg, F. Lewis, 2019, Translational behavioral medicine.

Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence score as an exemplar.

R. Street, C. Isaacs, S. Vadaparampil, 2020, Patient education and counseling.

The science of peer support as applied to behavioral medicine and the care of individuals surviving with cancer: a commentary on "Peer mentors delivering a physical activity intervention for cancer survivors: effects among mentors by Pinto et al."

C. Rini, K. Tercyak, K. Graves, 2018, Translational behavioral medicine.

Patient‐centered care and genomic medicine: A qualitative provider study in the military health system

C. Turner, S. O’Neill, L. Hellwig, 2019, Journal of genetic counseling.

Breast density in multiethnic women presenting for screening mammography

E. Makariou, C. Dash, K. Makambi, 2018, The breast journal.

Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial

Amanda L. Graham, J. Mandelblatt, D. Farrell, 2021, Journal of Cancer Education.

Physicians' perceptions of breast density notification laws and appropriate patient follow‐up

Mark A Manning, S. O’Neill, Kristen Purrington, 2021, The breast journal.

Predictors of nonadherence to breast cancer screening guidelines in a United States urban comprehensive cancer center

Mark A Manning, S. O’Neill, Kristen Purrington, 2023, Cancer medicine.

Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.

C. Isaacs, M. Schwartz, H. Tsai, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Motivations for genetic testing for lung cancer risk among young smokers

C. McBride, J. Shepperd, I. Lipkus, 2012, Tobacco Control.